FEED ENVUE MEDICAL INC. revenue, earnings and financials
For the quarter ended June 30, 2026, ENVUE MEDICAL INC. reported revenue of $239K (down 51.6% from a year earlier), net income of −$4.90M and diluted EPS of −$1.98; over the last four quarters revenue was $1.93M and net income −$21.1M; for the fiscal year ended December 2025 revenue was $2.55M, down 0.2% on the year before.
FEED annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $2.55M, gross profit $153K, operating income −$22.9M, net income −$18.2M (margin -712.3%), EPS −$26.69
- Fiscal year ended Dec 2024: revenue $2.56M, gross profit $1.51M, operating income −$3.58M, net income −$3.71M (margin -144.8%), EPS −$137.30
- Fiscal year ended Dec 2023: revenue $2.28M, gross profit $1.54M, operating income −$3.44M, net income −$3.71M (margin -162.5%), EPS −$23.32
- Fiscal year ended Dec 2022: revenue $752K, gross profit $167K, operating income −$5.01M, net income −$5.45M (margin -724.5%), EPS −$3.84
- Fiscal year ended Dec 2021: revenue $1.70M, gross profit $770K, operating income −$5.68M, net income −$14.3M (margin -842.6%), EPS −$0.57
FEED quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $239K (down 51.6% year over year), net income −$4.90M, EPS −$1.98
- Quarter ended Mar 31, 2026: revenue $653K (down 36.3% year over year), net income −$3.82M, EPS −$6.88
- Quarter ended Dec 31, 2025 (from the annual report): revenue $312K (down 29.7% year over year), net income −$12.9M, EPS $5.15
- Quarter ended Sep 30, 2025: revenue $722K (up 92.0% year over year), net income $510K, EPS −$0.91
- Quarter ended Jun 30, 2025: revenue $494K (down 39.5% year over year), net income −$3.97M, EPS −$1.03
- Quarter ended Mar 31, 2025: revenue $1.03M (up 11.3% year over year), net income −$1.87M, EPS −$29.90
- Quarter ended Dec 31, 2024 (from the annual report): revenue $444K (down 62.3% year over year), net income −$1.43M, EPS −$108.94
- Quarter ended Sep 30, 2024: revenue $376K (down 17.9% year over year), net income −$998K, EPS −$3.56
- Quarter ended Jun 30, 2024: revenue $817K (up 177.9% year over year), net income −$688K, EPS −$27.18
- Quarter ended Mar 31, 2024: revenue $921K (up 160.2% year over year), net income −$588K, EPS $2.38
- Quarter ended Dec 31, 2023 (from the annual report): revenue $1.18M (up 1253.9% year over year), net income −$813K, EPS −$21.58
- Quarter ended Sep 30, 2023: revenue $458K (up 372.2% year over year), net income −$727K, EPS −$0.42
- Quarter ended Jun 30, 2023: revenue $294K (down 39.4% year over year), net income −$1.07M, EPS −$0.65
- Quarter ended Mar 31, 2023: revenue $354K (up 30.1% year over year), net income −$1.10M, EPS −$0.67
- Quarter ended Dec 31, 2022 (from the annual report): revenue −$102K (down 113.2% year over year), net income −$2.06M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $97.0K (down 80.6% year over year), net income −$955K, EPS −$0.68
- Quarter ended Jun 30, 2022: revenue $485K (up 52.5% year over year), net income −$1.30M, EPS −$0.93
- Quarter ended Mar 31, 2022: revenue $272K (up 164.1% year over year), net income −$1.13M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $775K, net income −$2.47M, EPS −$0.10
- Quarter ended Sep 30, 2021: revenue $499K, net income −$6.68M, EPS −$0.26
FEED cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$9.37M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$2.52M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$3.60M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$7.04M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$4.37M, share buybacks n/a
FEED balance sheet
- Jun 30, 2026: cash $1.08M, total assets $38.4M, total liabilities $7.65M, shareholders' equity $30.8M
- Mar 31, 2026: cash $2.24M, total assets $39.9M, total liabilities $7.86M, shareholders' equity $32.0M
- Dec 31, 2025: cash $4.22M, total assets $41.1M, total liabilities $7.63M, shareholders' equity $33.5M
- Sep 30, 2025: cash $6.95M, total assets $54.4M, total liabilities $11.9M, shareholders' equity $42.5M
- Jun 30, 2025: cash $4.03M, total assets $51.5M, total liabilities $11.0M, shareholders' equity $40.5M
- Mar 31, 2025: cash $571K, total assets $44.1M, total liabilities $8.43M, shareholders' equity $35.7M
- Dec 31, 2024: cash $752K, total assets $3.63M, total liabilities $3.00M, shareholders' equity $627K
- Sep 30, 2024: cash $1.31M, total assets $4.68M, total liabilities $2.81M, shareholders' equity $1.87M
What is FEED's revenue?
ENVUE MEDICAL INC. reported $1.93M of revenue over its last four quarters, through June 30, 2026.
Is FEED profitable?
No. ENVUE MEDICAL INC. lost $21.1M over the last four quarters.
What is FEED's EPS?
Diluted earnings per share over the last four quarters were −$4.62; −$1.98 in the latest quarter.